BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 166311)

  • 21. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract.
    Holyoke D; Reynoso G; Chu TM
    Ann Surg; 1972 Oct; 176(4):559-64. PubMed ID: 5077412
    [No Abstract]   [Full Text] [Related]  

  • 22. [Carcinoembryonic antigen (CEA) test. A prospective clinical study of patients with gastrointestinal cancer].
    Kjaer M; Fischerman K
    Ugeskr Laeger; 1975 Jul; 137(31):1767-74. PubMed ID: 1154523
    [No Abstract]   [Full Text] [Related]  

  • 23. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
    Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
    Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
    [No Abstract]   [Full Text] [Related]  

  • 24. [Carcinoembryonic antigen in oncology].
    Tkacheva GA
    Med Radiol (Mosk); 1983 Aug; 28(8):69-76. PubMed ID: 6310310
    [No Abstract]   [Full Text] [Related]  

  • 25. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation.
    Denk H; Tappeiner G; Eckerstorfer R; Holzner JH
    Int J Cancer; 1972 Sep; 10(2):262-72. PubMed ID: 4350187
    [No Abstract]   [Full Text] [Related]  

  • 26. [Demonstration of common antigenic determinants between the carcinoembryonic antigen of the digestive tract and a glycoprotein extract of normal tissues].
    Pusztaszeri G; Mach JP; Dysli M
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1157-61. PubMed ID: 4115517
    [No Abstract]   [Full Text] [Related]  

  • 27. A study of plasma CEA by a direct radioimmunoassay method in 1704 cases.
    Mor C; Orefice S; Rocco F; Ferrara R; Biancardi C; Accinni R; Bartorelli A
    Neoplasma; 1977; 24(3):345-52. PubMed ID: 895944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introductory immunologic studies on human gastrointestinal tract tumors.
    Harlonzińska A; Glazman H; Woźniewski A; Albert Z; Richter R
    Arch Immunol Ther Exp (Warsz); 1973; 21(6):849-61. PubMed ID: 4131722
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
    Kahn HJ; Yeger H; Loftus R; Goldrosen MH
    Am J Pathol; 1989 Mar; 134(3):641-9. PubMed ID: 2466406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological diagnosis and prognosis of digestive tract cancer: some clinical considerations.
    Zamcheck N
    Ann Immunol (Paris); 1973 Nov; 124(4):635-40. PubMed ID: 4792503
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical significance of serum CA125 values in patients with cancers of the digestive system.
    Haga Y; Sakamoto K; Egami H; Yoshimura R; Mori K; Akagi M
    Am J Med Sci; 1986 Jul; 292(1):30-4. PubMed ID: 3459357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoembryonic antigen in benign and malignant diseases of the digestive tract.
    Zamcheck N; Moore TL; Dhar P; Kupchik HZ; Sorokin JJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():433-9. PubMed ID: 4659055
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
    Heptner G; Domschke S; Domschke W
    Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma carcinoembryonic antigen in an Australian hospital population.
    Frost MA; Coates AS
    Med J Aust; 1976 Jun; 1(25):950-3. PubMed ID: 979758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of carcinoembryonic antigen in serum of patients by using a technique of passive hemagglutination inhibition.
    Anthony RL; Sosnowski KM
    Clin Immunol Immunopathol; 1975 Sep; 4(3):362-73. PubMed ID: 1192614
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status of carcinoembryonic antigen assay.
    Chu TM
    Semin Nucl Med; 1975 Jul; 5(3):255-62. PubMed ID: 1154032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A collaborative clinical study of carcinoembryonic antigen in Japan.
    Hirai H
    Cancer Res; 1977 Jul; 37(7 Pt 1):2267-74. PubMed ID: 67888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.